STAT+: A promising sickle cell pill and a new way to treat myelofibrosis
This is the online version of ASH in 30 Seconds, STAT’s report from the American Society of Hematology meeting. Sign up for the email version here.
It’s Day 2 of the ASH meeting. Let’s get straight into the news.
Fulcrum study suggests improved efficacy for higher dose sickle cell pill
Fulcrum Therapeutics said Sunday that a higher dose of its experimental pill for sickle cell disease was more effective at inducing an alternative form of the oxygen-carrying molecule hemoglobin — boosting hopes it could one day provide a simple and effective treatment for the disease.
STAT Staff, Adam Feuerstein, Damian Garde, Katherine MacPhail, and Angus Chen
Go to statnews